Literature DB >> 16914875

Mutations in the tau gene (MAPT) in FTDP-17: the family with Multiple System Tauopathy with Presenile Dementia (MSTD).

Maria Grazia Spillantini1, Jill R Murrell, Michel Goedert, Martin Farlow, Aaron Klug, Bernardino Ghetti.   

Abstract

Work in 1980s and early 1990s established that the microtubule-associated protein tau is the major component of the paired helical filament of Alzheimer's disease. Similar filamentous deposits are also present in a number of other diseases, including progressive supranuclear palsy, corticobasal degeneration and Pick's disease. In 1998, the relevance of tau dysfunction for the neurodegenerative process became clear, when mutations in the tau gene were found to cause the inherited "frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)". The paper highlighted here [Spillantini M.G., Murrell J.R., Goedert M., Farlow M., Klug A. and Ghetti B. (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. USA 95, 7737-7741] reported a mutation at position + 3 in the intron following alternatively spliced exon 10 of the tau gene in a family.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16914875     DOI: 10.3233/jad-2006-9s342

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  7 in total

Review 1.  Natural Bioactive Products and Alzheimer's Disease Pathology: Lessons from Caenorhabditis elegans Transgenic Models.

Authors:  María D Navarro-Hortal; Jose M Romero-Márquez; Safa Osta; Victoria Jiménez-Trigo; Pedro Muñoz-Ollero; Alfonso Varela-López
Journal:  Diseases       Date:  2022-05-13

2.  Sleep Architecture Changed Without RBD in Patients With FTDP-17.

Authors:  Jia Liu; Shuqin Zhan; Chaoyang Huang; Yang Liu; Lin Liu; Liyong Wu; Yuping Wang
Journal:  J Clin Sleep Med       Date:  2018-10-15       Impact factor: 4.062

Review 3.  Stress-induced tau phosphorylation: functional neuroplasticity or neuronal vulnerability?

Authors:  Robert A Rissman
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

4.  Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau.

Authors:  Wenkai Li; Jeffrey B Sperry; Alex Crowe; John Q Trojanowski; Amos B Smith; Virginia M-Y Lee
Journal:  J Neurochem       Date:  2009-06-15       Impact factor: 5.372

5.  Multiple signaling factors and drugs alleviate neuronal death induced by expression of human and zebrafish tau proteins in vivo.

Authors:  Bo-Kai Wu; Rey-Yue Yuan; Huang-Wei Lien; Chin-Chun Hung; Pung-Pung Hwang; Rita Pei-Yeh Chen; Chun-Che Chang; Yung-Feng Liao; Chang-Jen Huang
Journal:  J Biomed Sci       Date:  2016-02-06       Impact factor: 8.410

6.  The Distance between N and C Termini of Tau and of FTDP-17 Mutants Is Modulated by Microtubule Interactions in Living Cells.

Authors:  Cristina Di Primio; Valentina Quercioli; Giacomo Siano; Matteo Rovere; Branislav Kovacech; Michal Novak; Antonino Cattaneo
Journal:  Front Mol Neurosci       Date:  2017-06-30       Impact factor: 5.639

Review 7.  TDP-43 Pathology in Alzheimer's Disease.

Authors:  Axel Meneses; Shunsuke Koga; Justin O'Leary; Dennis W Dickson; Guojun Bu; Na Zhao
Journal:  Mol Neurodegener       Date:  2021-12-20       Impact factor: 14.195

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.